Crohn's Disease
Show Only Open Trials
1.
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
- Study Status: Open to Enrollment
- Sponsor: Janssen
- Disease Status and/or Stage: Moderate to Severe Crohn's Disease
2.
Evaluation of PROCHYMAL Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease
- Study Status: Open to Enrollment
- Sponsor: Osiris
- Disease Status and/or Stage: Moderate to Severe Crohn's Disease
- Protocol ID: Osiris 603
3.
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
- Study Status: Open to Enrollment
- Sponsor: Elan Pharmaceuticals
- Disease Status and/or Stage: Crohn's Disease Being Treated with TYSABRI
4.
The Multi-Center African American IBD Study (MAAIS)
- Study Status: Open to Enrollment
- Sponsor: National Institutes of Digestive Diseases and Kidney (NIDDK)
- Disease Status and/or Stage: African-Americans with IBD, a Family Member with IBD, or Healthy Volunteers
5.
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease
- Study Status: Open to Enrollment
- Sponsor: Crohn’s Colitis Foundation Clinical Alliance
- Disease Status and/or Stage: Pregnant Women with Crohn's Disease or Ulcerative Colitis
